• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

NIDA IRP

National Institute on Drug Abuse - Intramural Research Program

  National Institute on Drug Abuse | NIH IRP | Treatment Info | Emergency Contacts
  • Home
  • News
    • Featured Paper of the Month
    • Reviews to Read
    • Hot off the Press
    • IRP News
    • Awards
    • Technology Development Initiative Paper of the Month
    • Seminar Series
    • Addiction Grand Rounds
  • About
    • About NIDA IRP
    • Contact Us
    • Directions and Map
    • Careers at NIDA IRP
    • Emergency Contacts
    • Employee Assistance Resources
  • Organization
    • Faculty
    • Office of the Scientific Director
    • Office of the Clinical Director
    • Office of Education and Career Development
    • Administrative Management Branch
    • Molecular Targets and Medications Discovery Branch
    • Cellular and Neurocomputational Systems Branch
    • Molecular Neuropsychiatry Research Branch
    • Neuroimaging Research Branch
    • Behavioral Neuroscience Research Branch
    • Integrative Neuroscience Research Branch
    • Translational Addiction Medicine Branch
    • Core Facilities
    • Community Outreach Group
  • Training Programs
    • Office of Education and Career Development
    • OECD Awards
    • Summer Internship Program
    • Postbaccalaureate Program
    • Graduate Partnership Program
    • Postdoctoral Program
    • NIDA Speakers Bureau
    • Clinical Electives Program
    • Clinical Mentoring Program
  • Study Volunteers

Andras Leko, M.D., Ph.D.

Andras Leko, M.D., Ph.D.

Position

Former Visiting Fellow, Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section

Contact

Biomedical Research Center
251 Bayview Boulevard
Suite 200
Room 02A406
Baltimore, MD 21224

Email: andras.leko@nih.gov

Background

Dr. Andras H. Leko joined Dr. Leggio’s CPN laboratory in August 2021. He received both his M.D. and Ph.D. in Neuroscience from Semmelweis University of Budapest, Hungary. In 2015-2017, Dr. Leko was a Ph.D. fellow in the Laboratory of Neuromorphology, Semmelweis University and an assistant research fellow in the Laboratory of Molecular and Systems Neurobiology, Eötvös Loránd University. His primary research focused on neural circuits responsible for maternal behavior. Dr. Leko began his residency in Psychiatry in 2017 and defended his doctoral thesis in 2018 in the Department of Psychiatry and Psychotherapy at Semmelweis University, Budapest. He identified insulin-like growth factor-1 (IGF-1) as a novel regulator of prolactin release and maternal motivation. More recently, he has applied transcriptome sequencing approaches to investigate genes responsible for maternal adaptation of the central nervous system and identified a potential role of the androgen receptor in the control of maternal behaviour. Dr. Leko’s efforts have been acknowledged with a 2016 Best Presentation Award at the Scientific Conference of Hungarian Associations of Pharmacology, Anatomy, Microcirculation and Physiology and have been awarded by the Hungarian New National Excellence Program of the Ministry of Human Capacities. Dr. Leko’s research on neuroendocrine pathways and neuroscience continues as a Visiting Fellow in Dr. Leggio’s lab.

Selected Publications

2024

Lékó, András H; Gregory-Flores, Adriana; Marchette, Renata C N; Gomez, Juan L; Vendruscolo, Janaina C M; Repunte-Canonigo, Vez; Choung, Vicky; Deschaine, Sara L; Whiting, Kimberly E; Jackson, Shelley N; Cornejo, Maria Paula; Perello, Mario; You, Zhi-Bing; Eckhaus, Michael; Rasineni, Karuna; Janda, Kim D; Zorman, Barry; Sumazin, Pavel; Koob, George F; Michaelides, Michael; Sanna, Pietro P; Vendruscolo, Leandro F; Leggio, Lorenzo

Genetic or pharmacological GHSR blockade has sexually dimorphic effects in rodents on a high-fat diet Journal Article

In: Commun Biol, vol. 7, no. 1, pp. 632, 2024, ISSN: 2399-3642.

Abstract | Links

@article{pmid38796563,
title = {Genetic or pharmacological GHSR blockade has sexually dimorphic effects in rodents on a high-fat diet},
author = {András H Lékó and Adriana Gregory-Flores and Renata C N Marchette and Juan L Gomez and Janaina C M Vendruscolo and Vez Repunte-Canonigo and Vicky Choung and Sara L Deschaine and Kimberly E Whiting and Shelley N Jackson and Maria Paula Cornejo and Mario Perello and Zhi-Bing You and Michael Eckhaus and Karuna Rasineni and Kim D Janda and Barry Zorman and Pavel Sumazin and George F Koob and Michael Michaelides and Pietro P Sanna and Leandro F Vendruscolo and Lorenzo Leggio},
doi = {10.1038/s42003-024-06303-5},
issn = {2399-3642},
year = {2024},
date = {2024-05-01},
urldate = {2024-05-01},
journal = {Commun Biol},
volume = {7},
number = {1},
pages = {632},
abstract = {The stomach-derived hormone ghrelin regulates essential physiological functions. The ghrelin receptor (GHSR) has ligand-independent actions; therefore, GHSR gene deletion may be a reasonable approach to investigate the role of this system in feeding behaviors and diet-induced obesity (DIO). Here, we investigate the effects of a long-term (12-month) high-fat (HFD) versus regular diet on obesity-related measures in global GHSR-KO and wild-type (WT) Wistar male and female rats. Our main findings are that the GHSR gene deletion protects against DIO and decreases food intake during HFD in male but not in female rats. GHSR gene deletion increases thermogenesis and brain glucose uptake in male rats and modifies the effects of HFD on brain glucose metabolism in a sex-specific manner, as assessed with small animal positron emission tomography. We use RNA-sequencing to show that GHSR-KO rats have upregulated expression of genes responsible for fat oxidation in brown adipose tissue. Central administration of a novel GHSR inverse agonist, PF-5190457, attenuates ghrelin-induced food intake, but only in male, not in female mice. HFD-induced binge-like eating is reduced by inverse agonism in both sexes. Our results support GHSR as a promising target for new pharmacotherapies for obesity.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}

Close

The stomach-derived hormone ghrelin regulates essential physiological functions. The ghrelin receptor (GHSR) has ligand-independent actions; therefore, GHSR gene deletion may be a reasonable approach to investigate the role of this system in feeding behaviors and diet-induced obesity (DIO). Here, we investigate the effects of a long-term (12-month) high-fat (HFD) versus regular diet on obesity-related measures in global GHSR-KO and wild-type (WT) Wistar male and female rats. Our main findings are that the GHSR gene deletion protects against DIO and decreases food intake during HFD in male but not in female rats. GHSR gene deletion increases thermogenesis and brain glucose uptake in male rats and modifies the effects of HFD on brain glucose metabolism in a sex-specific manner, as assessed with small animal positron emission tomography. We use RNA-sequencing to show that GHSR-KO rats have upregulated expression of genes responsible for fat oxidation in brown adipose tissue. Central administration of a novel GHSR inverse agonist, PF-5190457, attenuates ghrelin-induced food intake, but only in male, not in female mice. HFD-induced binge-like eating is reduced by inverse agonism in both sexes. Our results support GHSR as a promising target for new pharmacotherapies for obesity.

Close

  • doi:10.1038/s42003-024-06303-5

Close

2021

Lékó, András H; Kumari, Rashmi; Dóra, Fanni; Keller, Dávid; Udvari, Edina B; Csikós, Vivien; Renner, Éva; Dobolyi, Arpád

Transcriptome Sequencing in the Preoptic Region of Rat Dams Reveals a Role of Androgen Receptor in the Control of Maternal Behavior Journal Article

In: Int J Mol Sci, vol. 22, no. 4, 2021, ISSN: 1422-0067.

Abstract | Links

@article{pmid33546359,
title = {Transcriptome Sequencing in the Preoptic Region of Rat Dams Reveals a Role of Androgen Receptor in the Control of Maternal Behavior},
author = {András H Lékó and Rashmi Kumari and Fanni Dóra and Dávid Keller and Edina B Udvari and Vivien Csikós and Éva Renner and Arpád Dobolyi},
url = {https://pubmed.ncbi.nlm.nih.gov/33546359/},
doi = {10.3390/ijms22041517},
issn = {1422-0067},
year = {2021},
date = {2021-02-01},
urldate = {2021-02-01},
journal = {Int J Mol Sci},
volume = {22},
number = {4},
abstract = {(1) Background: Preoptic region of hypothalamus is responsible to control maternal behavior, which was hypothesized to be associated with gene expressional changes. (2) Methods: Transcriptome sequencing was first applied in the preoptic region of rat dams in comparison to a control group of mothers whose pups were taken away immediately after parturition and did not exhibit caring behavior 10 days later. (3) Results: Differentially expressed genes were found and validated by quantitative RT-PCR, among them NACHT and WD repeat domain containing 1 (Nwd1) is known to control androgen receptor (AR) protein levels. The distribution of Nwd1 mRNA and AR was similar in the preoptic area. Therefore, we focused on this steroid hormone receptor and found its reduced protein level in rat dams. To establish the function of AR in maternal behavior, its antagonist was administered intracerebroventricularly into mother rats and increased pup-directed behavior of the animals. (4) Conclusions: AR levels are suppressed in the preoptic area of mothers possibly mediated by altered Nwd1 expression in order to allow sustained high-level care for the pups. Thus, our study first implicated the AR in the control of maternal behaviors.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}

Close

(1) Background: Preoptic region of hypothalamus is responsible to control maternal behavior, which was hypothesized to be associated with gene expressional changes. (2) Methods: Transcriptome sequencing was first applied in the preoptic region of rat dams in comparison to a control group of mothers whose pups were taken away immediately after parturition and did not exhibit caring behavior 10 days later. (3) Results: Differentially expressed genes were found and validated by quantitative RT-PCR, among them NACHT and WD repeat domain containing 1 (Nwd1) is known to control androgen receptor (AR) protein levels. The distribution of Nwd1 mRNA and AR was similar in the preoptic area. Therefore, we focused on this steroid hormone receptor and found its reduced protein level in rat dams. To establish the function of AR in maternal behavior, its antagonist was administered intracerebroventricularly into mother rats and increased pup-directed behavior of the animals. (4) Conclusions: AR levels are suppressed in the preoptic area of mothers possibly mediated by altered Nwd1 expression in order to allow sustained high-level care for the pups. Thus, our study first implicated the AR in the control of maternal behaviors.

Close

  • https://pubmed.ncbi.nlm.nih.gov/33546359/
  • doi:10.3390/ijms22041517

Close

2017

Lékó, András H; Cservenák, Melinda; Szabó, Éva Rebeka; Hanics, János; Alpár, Alán; Dobolyi, Árpád

Insulin-like growth factor I and its binding protein-3 are regulators of lactation and maternal responsiveness Journal Article

In: Sci Rep, vol. 7, no. 1, pp. 3396, 2017, ISSN: 2045-2322.

Abstract | Links

@article{pmid28611445,
title = {Insulin-like growth factor I and its binding protein-3 are regulators of lactation and maternal responsiveness},
author = {András H Lékó and Melinda Cservenák and Éva Rebeka Szabó and János Hanics and Alán Alpár and Árpád Dobolyi},
url = {https://pubmed.ncbi.nlm.nih.gov/28611445/},
doi = {10.1038/s41598-017-03645-5},
issn = {2045-2322},
year = {2017},
date = {2017-01-01},
urldate = {2017-01-01},
journal = {Sci Rep},
volume = {7},
number = {1},
pages = {3396},
abstract = {Adaptation to motherhood includes maternal behaviour and lactation during the postpartum period. The major organizing centres of maternal behaviour and lactation are located in the hypothalamic medial preoptic area (MPOA) and the arcuate nucleus, respectively. Insulin-like growth factor I (IGF-I) is an effector of the growth hormone axis; however, its function in the brain is largely unexplored. We identified increased maternal IGF binding protein-3 (IGFBP-3) expression in preoptic rat microarray data and confirmed it by RT-PCR. In situ hybridization histochemistry showed markedly elevated IGFBP-3 expression in the MPOA and the arcuate nucleus in rat dams. Prolonged intracerebroventricular injection of IGF-I or antagonism of brain IGFBP-3 with an inhibitor (NBI-31772) using osmotic minipumps increased pup retrieval time, suggesting reduced maternal motivation. Suckling-induced prolactin release and pup weight gain were also suppressed by IGF-I, suggesting reduced lactation. In addition, IGF-I-induced tyrosine hydroxylase expression and its specific phosphorylation in tuberoinfundibular dopaminergic neurons suppress prolactin secretion. Thus, IGF-I may inhibit both behavioural and lactational alterations in mothers. Neurons in the MPOA and arcuate nuclei express IGFBP-3 during the postpartum period to neutralize IGF-I effects. IGFBP-3 can prevent the blockade of maternal behaviour and lactation exerted by IGF-I, suggesting a novel modulatory mechanism underlying the behavioural and hormonal effects during central maternal adaptations.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}

Close

Adaptation to motherhood includes maternal behaviour and lactation during the postpartum period. The major organizing centres of maternal behaviour and lactation are located in the hypothalamic medial preoptic area (MPOA) and the arcuate nucleus, respectively. Insulin-like growth factor I (IGF-I) is an effector of the growth hormone axis; however, its function in the brain is largely unexplored. We identified increased maternal IGF binding protein-3 (IGFBP-3) expression in preoptic rat microarray data and confirmed it by RT-PCR. In situ hybridization histochemistry showed markedly elevated IGFBP-3 expression in the MPOA and the arcuate nucleus in rat dams. Prolonged intracerebroventricular injection of IGF-I or antagonism of brain IGFBP-3 with an inhibitor (NBI-31772) using osmotic minipumps increased pup retrieval time, suggesting reduced maternal motivation. Suckling-induced prolactin release and pup weight gain were also suppressed by IGF-I, suggesting reduced lactation. In addition, IGF-I-induced tyrosine hydroxylase expression and its specific phosphorylation in tuberoinfundibular dopaminergic neurons suppress prolactin secretion. Thus, IGF-I may inhibit both behavioural and lactational alterations in mothers. Neurons in the MPOA and arcuate nuclei express IGFBP-3 during the postpartum period to neutralize IGF-I effects. IGFBP-3 can prevent the blockade of maternal behaviour and lactation exerted by IGF-I, suggesting a novel modulatory mechanism underlying the behavioural and hormonal effects during central maternal adaptations.

Close

  • https://pubmed.ncbi.nlm.nih.gov/28611445/
  • doi:10.1038/s41598-017-03645-5

Close

Primary Sidebar

Organization

  • Organization
  • Faculty
  • Office of the Scientific Director
  • Office of the Clinical Director
  • Administrative Management Branch
  • Molecular Targets and Medications Discovery Branch
  • Cellular and Neurocomputational Systems Branch
  • Molecular Neuropsychiatry Research Branch
  • Neuroimaging Research Branch
  • Behavioral Neuroscience Research Branch
  • Integrative Neuroscience Research Branch
  • Translational Addiction Medicine Branch
  • Core Facilities
  • Careers at NIDA IRP
  • Technology Development Initiative
  • Community Outreach Group
Home / Staff Members / Andras Leko, M.D., Ph.D.
  • National Institute on Drug Abuse
  • NIH Intramural Research Program
  • National Institutes of Health
  • Health and Human Services
  • USA.GOV
  • Emergency Contacts
  • Employee Assistance
  • Treatment Information
  • Contact Us
  • Careers at NIDA IRP
  • Accessibility
  • Privacy
  • HHS Vulnerability Disclosure
  • Freedom of Information Act
  • Document Viewing Tools
  • Offsite Links
  • National Institute on Drug Abuse
  • NIH Intramural Research Program
  • National Institutes of Health
  • Health and Human Services
  • USA.GOV
  • Emergency Contacts
  • Employee Assistance
  • Treatment Information
  • Contact Us
  • Careers at NIDA IRP
  • Accessibility
  • Privacy
  • HHS Vulnerability Disclosure
  • Freedom of Information Act
  • Document Viewing Tools
  • Offsite Links

  • Home
  • News
    ▼
    • Featured Paper of the Month
    • Reviews to Read
    • Hot off the Press
    • IRP News
    • Awards
    • Technology Development Initiative Paper of the Month
    • Seminar Series
    • Addiction Grand Rounds
  • About
    ▼
    • About NIDA IRP
    • Contact Us
    • Directions and Map
    • Careers at NIDA IRP
    • Emergency Contacts
    • Employee Assistance Resources
  • Organization
    ▼
    • Faculty
    • Office of the Scientific Director
    • Office of the Clinical Director
    • Office of Education and Career Development
    • Administrative Management Branch
    • Molecular Targets and Medications Discovery Branch
    • Cellular and Neurocomputational Systems Branch
    • Molecular Neuropsychiatry Research Branch
    • Neuroimaging Research Branch
    • Behavioral Neuroscience Research Branch
    • Integrative Neuroscience Research Branch
    • Translational Addiction Medicine Branch
    • Core Facilities
    • Community Outreach Group
  • Training Programs
    ▼
    • Office of Education and Career Development
    • OECD Awards
    • Summer Internship Program
    • Postbaccalaureate Program
    • Graduate Partnership Program
    • Postdoctoral Program
    • NIDA Speakers Bureau
    • Clinical Electives Program
    • Clinical Mentoring Program
  • Study Volunteers